Annual report [Section 13 and 15(d), not S-K Item 405]

Net Loss per Share of Common Stock

v3.26.1
Net Loss per Share of Common Stock
12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Loss per Share of Common Stock

Note 5 – Net Loss per Share of Common Stock

 

Basic net loss per share is computed by dividing net loss by the weighted average common stock outstanding (which excludes unvested RSAs) and vested, but unissued RSUs. Diluted net loss per share is computed by dividing net loss by the diluted weighted average common stock outstanding, which includes potentially dilutive effect of stock options, unvested RSAs, unvested RSUs and warrants. The treasury-stock method is used to determine the dilutive effect of our stock options and warrant grants. Since we experienced a loss for both periods presented, basic and diluted net loss per share are the same and, as they would have an anti-dilutive impact on diluted net loss per share, any dilutive common shares outstanding were excluded from the computation shown below.

 

The computation of net loss per share for the year ended December 31, 2025 and 2024 was as follows:

 

    2025     2024  
Basic and diluted net loss per share:                
Net loss available to common shareholders   $ (13,563,834 )   $ (11,850,118 )
Weighted-average number of common shares-basic and diluted     1,309,271       122,438  
                 
Basic and diluted net loss per share   $ (10.36 )   $ (96.78 )

 

    2025     2024  
Weighted-average number of common shares outstanding – basic and diluted     1,299,055       116,503  
Weighted-average number of vested RSUs– basic and diluted     10,216       5,935  
Weighted-average number of common shares-basic and diluted     1,309,271       122,438  

 

As described in Note 3, we issued various equity instruments during the years ended December 31, 2025 and 2024 which impact our EPS calculation. Vested RSUs are included in our computation of the weighted average shares for basic EPS and unvested RSUs are included as dilutive securities. At December 31, 2025 and 2024, 46,303 and 9,388 unvested RSUs, respectively, were excluded from the EPS calculation.

 

 

The outstanding stock options, unvested RSAs, unvested RSUs and warrants to purchase common stock were excluded from the computation of diluted net loss per share as their effect would have been anti-dilutive for the periods presented below:

 

    2025     2024  
Stock options, unvested RSUs, and purchase warrants     1,636,573       80,537